Alkalon is a privately owned Danish-Swedish pharmaceutical company engaged in formulation development and supply of over-the-counter medicinal products.

The business operates from its head office in Copenhagen and in-house R&D activities take place in a laboratory in Vejle.

Alkalon's primary focus is launch of a portfolio of new, improved nicotine gum formulations.

We operate in the middle of the pharmaceutical value chain and have entered strategic partnerships and supply agreements with a range of well-known pharmaceutical companies in Europe and elsewhere.